Papanicolaou Test Can Detect HPV-negative Squamous and Glandular Abnormalities Missed by Primary HPV Screening

2021 ◽  
Vol 10 (5) ◽  
pp. S3-S4
Author(s):  
Amelia Donlan ◽  
Verena Grieco ◽  
Eric Huang
Keyword(s):  
Papanicolaou Test ◽  
Hpv Screening

The Effect of Hysterectomy on the Risk of an Abnormal Screening Papanicolaou Test Result

2000 ◽  
Vol 4 (2) ◽  
pp. 115-115
Author(s):  
J Fox ◽  
P Remington ◽  
P Layde ◽  
G Klein
Keyword(s):  
Papanicolaou Test ◽  
Test Result

Human papillomavirus lesions in 16 MS patients treated with fingolimod: Outcomes and vaccination

2021 ◽  
pp. 135245852199143
Author(s):  
Elsa Mhanna ◽  
Agathe Nouchi ◽  
Céline Louapre ◽  
Raphael De Paz ◽  
Olivier Heinzlef ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Human Papillomavirus ◽  
Hpv Vaccination ◽  
Case Series ◽  
Good Tolerance ◽  
Prevalence Studies ◽  
Disease Modifying Therapies ◽  
Disease Modifying ◽  
Hpv Screening

Few cases of human papillomavirus (HPV) diseases have been reported in multiple sclerosis (MS) patients treated with fingolimod. We describe a case series of 16 MS patients (11 women, 5 men) developing HPV lesions after the onset of fingolimod, without previous HPV history. Fingolimod had to be discontinued in six patients. Six patients received vaccination for HPV, with good tolerance. Our report highlights that systematic HPV screening and discussion about HPV vaccination before fingolimod onset are crucial. In case of occurrence of HPV lesions during fingolimod treatment, a comprehensive workup of HPV disease is necessary, with discussion of HPV vaccination to prevent secondary lesions. Prevalence studies of HPV lesions are needed in MS patients with the different disease-modifying therapies.

The Papanicolaou Test in Elderly Women

JAMA ◽  
1986 ◽  
Vol 256 (3) ◽  
pp. 393 ◽  
Author(s):  
Donald E. Riesenberg
Keyword(s):  
Elderly Women ◽  
Papanicolaou Test
Sign in / Sign up

Export Citation Format

Share Document